Ayala Pharmaceuticals Inc. (AYLA)

Data Milestones Reiterated With 1Q22 Financial Report


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
May 17, 2022
Report ID: 24868
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Ayala Pharmaceuticals Inc.
Ayala Pharmaceuticals Inc.
Healthcare
Biotechnology
Ticker
AYLA
Current Price
$0.5501 0.02%
Market Cap
$8.2M
Price Target
Refer to Report
Volume
25.5K
52wk Range
$0.4631 - $10.53
Related Research Reports
10/20/2022

Ayala Announces Merger With Advaxis
Ayala Announces Merger With Advaxis (AYLA)
10/7/2022

Ayala Holds KOL Event On AL102 and Desmoid Tumors
Ayala Holds KOL Event On AL102 and Desmoid Tumors (AYLA)
9/20/2022

Lowering AYLA To Market Perform
Lowering AYLA To Market Perform (AYLA)
9/14/2022

Phase 2/3 RINGSIDE Data Presented, Dose Selected For Next Stage
Phase 2/3 RINGSIDE Data Presented, Dose Selected For Next Stage (AYLA)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.